Ceva Santé Animale is taking an active role in helping wipe out chlamydia in Australian koalas, donating supplies to animal health centers and one of the continent's top zoos to cure animals of the sexually transmitted disease.
An international entrepreneurial trio has developed a hand-worn ring that detects syphilis, gonorrhea, chlamydia and trichomoniasis--wirelessly transmitting the results to a smartphone or tablet in under one minute. Known as Hoope, the device has a retractable needle and an anesthetic system based on electrical pulses; it is slated to debut on crowdfunding site Indiegogo in January.
Prokarium, which specializes in developing oral vaccines announced £377,000 ($585,000) in new funding from SynbiCITE, the U.K.'s Innovation and Knowledge Centre for Synthetic Biology. It will go toward the development of an oral chlamydia vaccine.
Researchers in the U.S. and China have worked together to develop microparticles that carry vaccine nanoparticles through the stomach and release them in the large intestine when the pH levels are on point.
The vaccine developer Genocea Biosciences has used its in-house proteomics screening technology, AnTigen Lead Acquisition System (ATLAS), to identify two potential candidates for C trachomatis vaccines.